Raymond James Financial’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$599K Sell
118,312
-128,491
-52% -$650K ﹤0.01% 3883
2025
Q1
$1.31M Buy
246,803
+156,696
+174% +$829K ﹤0.01% 3285
2024
Q4
$609K Buy
+90,107
New +$609K ﹤0.01% 3762